NBC SECURITIES, INC.

Broker-Dealer

Position in HALO — Halozyme Therapeutics, Inc.

CIK 791540 BIRMINGHAM, AL

Position in HALO

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$729,026

-$30,118 QoQ

Shares Held

11,280

0.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NBC SECURITIES, INC. holds $4,320,734 across 55 Biotechnology names. HALO ranks #1 (16.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	11,280	$729,026
2	REGN	Regeneron Pharmaceuticals, Inc.	436	$336,871
3	AXSM	Axsome Therapeutics, Inc.	1,793	$303,052
4	PTGX	Protagonist Therapeutics, Inc	2,547	$268,453
5	INBX	Inhibrx Biosciences, Inc.	3,800	$255,474
6	TSHA	Taysha Gene Therapies, Inc.	54,058	$241,639
7	BBIO	BridgeBio Pharma, Inc.	3,092	$229,611
8	MIRM	Mirum Pharmaceuticals, Inc.	2,420	$223,559

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$729,026	11,280	0.0%	Shares	Sole	2026-04-14
2025-12-31	$759,144	11,280	-3.1%	Shares	Sole	2026-01-29
2025-09-30	$853,970	11,644	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$604,836	11,627	-6.3%	Shares	Sole	2025-07-08
2025-03-31	$791,435	12,403	+620050.0%	Shares	Sole	2025-04-09
2024-12-31	$95	2	-99.9%	Shares	Sole	2025-01-22
2024-09-30	$131,823	2,303	-26.3%	Shares	Sole	2024-10-15
2024-06-30	$163,572	3,124	+155.6%	Shares	Sole	2024-07-10
2024-03-31	$49,710	1,222	0.0%	Shares	Sole	2024-04-05
2023-12-31	$45,165	1,222	-11.3%	Shares	Sole	2024-02-07
2023-09-30	$52,639	1,378	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.